5 Result(s)
-
Article
Open AccessPrognostic value of microRNA expression in operable non-small cell lung cancer patients
About 50% of non-small cell lung cancer (NSCLC) patients develop distant metastases following pulmonary resection. Currently, there are no reliable factors allowing for individual selection of high-risk patien...
-
Article
Open AccessIncreased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
To investigate whether copy number gain of MET or hepatocyte growth factor (HGF) affect trastuzumab sensitivity in HER2-positive metastatic breast cancer (MBC).
-
Article
Open AccessA prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)
A prospective randomised study compared two palliative radiotherapy schedules for inoperable symptomatic non-small-cell lung cancer (NSCLC). After stratification, 100 patients were randomly assigned to 20 Gy/5...
-
Article
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer
The EORTC Breast Cancer Cooperative Group carried out a randomized trial to compare doxorubicin with epirubicin as second-line chemotherapy in patients with metastatic breast cancer. Two hundred and fifty-nine...
-
Article
Post-operative radiotherapy in non-small-cell lung cancer: more questions than answers
